You just read:

HeartWare Receives 54-Patient Allotment From FDA Under Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical Trial

News provided by

HeartWare International, Inc.

Mar 16, 2012, 10:58 ET